Mark Elliott, MD
Assistant Professor
Psychiatry
School of Medicine

Publications (6)

Top publication keywords:
GenotypeRenal Insufficiency, ChronicRiskGlomerular Filtration RateHigh-Throughput Nucleotide SequencingOff-Label UseCentral Nervous System StimulantsInflammasomesCognitionApolipoprotein L1Prescription DrugsIntelligenceRenal InsufficiencyExtinction, PsychologicalKidney Diseases

• Increased risk of kidney failure in patients with genetic kidney disorders.
  The Journal of clinical investigation 2024 Elliott MD, Vena N, Marasa M, Cocchi E, Bheda S, Bogyo K, Shang N, Zanoni F, Verbitsky M, Wang C, Kolupaeva V, Jin G, Sofer M, Gras Pena R, Canetta PA, Bomback AS, Guay-Woodford LM, Hou J, Gillespie …
• Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
  Journal of the American Society of Nephrology : JASN 2023 Elliott MD, Marasa M, Cocchi E, Vena N, Zhang JY, Khan A, Krishna Murthy S, Bheda S, Milo Rasouly H, Povysil G, Kiryluk K, Gharavi AG
• Genetics of Kidney Disease: The Unexpected Role of Rare Disorders.
  Annual review of medicine 2022 Elliott MD, Rasouly HM, Gharavi AG
• Mainstreaming Genetic Testing for Adult Patients With Autosomal Dominant Polycystic Kidney Disease.
  Canadian journal of kidney health and disease 2021 Elliott MD, James LC, Simms EL, Sharma P, Girard LP, Cheema K, Elliott MJ, Lauzon JL, Chun J
• Altered fear learning across development in both mouse and human.
  Proceedings of the National Academy of Sciences of the United States of America 2012 Pattwell SS, Duhoux S, Hartley CA, Johnson DC, Jing D, Elliott MD, Ruberry EJ, Powers A, Mehta N, Yang RR, Soliman F, Glatt CE, Casey BJ, Ninan I, Lee FS
• Pharmacological cognitive enhancers: comment on Smith and Farah (2011).
  Psychological bulletin 2011 Elliott GR, Elliott MD